Skip to main content
Premium Trial:

Request an Annual Quote

Protein Design Labs Licenses Resolver Gene Expression Analysis System from Rosetta

NEW YORK, July 11 – Protein Design Labs has agreed to license the Rosetta Resolver gene expression data analysis system from Rosetta Inpharmatics and exclusive distributor Agilent Technologies, the companies said Wednesday.

Financial details were not disclosed.

The Resolver system accepts data from a wide variety of expression profiling formats, including Affymetrix GeneChip and Agilent DNA microarrays, and applies proprietary error models to calculate statistics on gene expression data. Rosetta, based in Kirkland, Wash., released version 2.0 of the system in the first quarter of 2001.

Protein Design Labs, of Fremont, Calif., develops “humanized” monoclonal antibodies, mouse or rat antiobodies that are modified for therapeutic applications in humans. Max Vasquez, director of target validation at Protein Design Labs, said in a statement that the company would use the Resolver system in its antibody target identification and validation programs.

In May, Merck acquired Rosetta for $620 million in stock, but said that Rosetta would continue to operate the Resolver business as a separate cost center. Rosetta has licensed its Resolver system to a number of pharmaceutical and biotechnology companies, including GlaxoSmithKline, Biogen, Immunex, Paradigm Genetics, and Merck.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.